Rejenevie Therapeutics is Biotechnology in United States that focus on robust immune system business. Founded in 2012. They cover business area such as developer, stem cell restoration therapy, age-relate disease, identify factor, young healthy individual, age stem cell, age cell, patient, a more robust immune system.
2012
( 12 years old in 2024 )
Robust Immune System
-
Okyanos Global Health Innovation Lab 9350 Kirby Drive
Suite 300
Houston, TX 77054
United States
Private
developerstem cell restoration therapyage-relate diseaseidentify factoryoung healthy individualage stem cellage cellpatienta more robust immune system
* We use standard office opening hours in near Rejenevie Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Rejenevie Therapeutics is Biotechnology business from United States that founded in 2012 (12 years old in 2024), Rejenevie Therapeutics business is focusing on Robust Immune System.
Rejenevie Therapeutics headquarter office and corporate office address is located in Okyanos Global Health Innovation Lab 9350 Kirby Drive Suite 300 Houston, TX 77054 United States.
Rejenevie Therapeutics was founded in United States.
In 2024, Rejenevie Therapeutics is currently focus on robust immune system sector.
Above is snippet of Google Trends for "robust immune system" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Rejenevie Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.